Przedsiębiorstwo Produkcji Farmaceutyczno-Kosmetycznej Profarmsp. z o.o.
Manufacture of pharmaceutical preparations
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2002-02-11
Share capital
864 000,00 PLN
Registered address
Słupska 18, 84-300 Lębork, Poland
Electronic delivery address
AE:PL-55425-52196-CCUTF-22
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.28mMedianUSD 816.16kAverageUSD 29.28m
Net profit
This companyUSD 29.74kMedianUSD 8.96kAverageUSD 2.64m
Operating costs
This companyUSD 2.09mMedianUSD 701.47kAverageUSD 19.26m
Assets
This companyUSD 2.00mMedianUSD 800.13kAverageUSD 29.34m
Industry
Bank accounts
Registered as a VAT taxpayer on 1993-07-05. Active
17 1240 3800 1111 0010 3357 6889
21 1240 3800 1111 0000 4460 8758
28 1240 3800 1111 0000 4460 8729
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
18 public aid cases recorded, with a total value of $473,036.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 28, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Prezes Banku Gospodarstwa Krajowego | |
| Jun 28, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Prezes Banku Gospodarstwa Krajowego | |
| Jun 28, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-09-01 | Opracowanie innowacyjnego dermokosmetyku o unikalnych właściwościach dla osób z bielactwem nabytym | $408.1K$408,147 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Beata Anna Roman — Management Board Member
Kamil Busłowicz — Management Board Member
Manner of representation
A minimum of two members of the management board, or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Andrzej Czernik (61) | 37 | $4,997.30 | 2.1412% |
Felix Familia Fundacja Rodzinna | 448 | $60,507.83 | 25.9259% |
Robert Maciej Szymański (57) | 37 | $4,997.30 | 2.1412% |
Others | 1,206 | $162,884.93 | 69.7917% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Mariusz Radosław Cięciara (47) | Beneficjent sprawuje kontrolę nad osobą prawną będącą właścicielem więcej niż 25% ogólnej liczby udziałów w kapitale zakładowym przedsiębiorstwa produkcji farmaceutyczno-kosmetycznej "profarm" spółka z ograniczoną odpowiedzialnością oraz dysponującą więcej niż 25% ogólnej liczby głosów w organie stanowiącym spółki, poprzez dysponowanie więcej niż 25% ogólnej liczby głosów w organie stanowiącym tej osoby prawnej | |
Robert Andrzej Czernik (61) | Shareholder of a limited liability company, 320000.0 PLN | |
Robert Maciej Szymański (57) | Shareholder of a limited liability company, 320000.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A. | $7,294,338.51 | herbapol.krakow.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-05 | Share capital change (50,000.00 PLN → 864,000.00 PLN) | |
| 2002-09-25 | Share capital change (10,000.00 PLN → 50,000.00 PLN) | |
| 2002-02-11 | Entered in the register |
FAQ
The main business activity of Przedsiębiorstwo Produkcji Farmaceutyczno-Kosmetycznej Profarm focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on February 11, 2002.
The headquarters is located at: Słupska 18, 84-300 Lębork.
The management board includes Kamil Busłowicz (Member of the Management Board).
The share capital of the company is PLN 864,000 (approx. $233,387).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 2,280,613, representing an increase of 28.3% compared to 2024.
Yes, in 2025 the company achieved a net profit of USD 29,738.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 1,198,871 in 2025, representing 57% of all operating expenses.
Last updated: 2026-10-04